DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 114 filers reported holding DYNE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,532,489 | -17.6% | 394,251 | +3.5% | 0.00% | 0.0% |
| Q2 2023 | $4,285,440 | +35.5% | 380,928 | +38.8% | 0.00% | 0.0% |
| Q1 2023 | $3,161,929 | -2.9% | 274,473 | -2.3% | 0.00% | 0.0% |
| Q4 2022 | $3,257,195 | -3.8% | 281,035 | +5.4% | 0.00% | 0.0% |
| Q3 2022 | $3,386,000 | +85.2% | 266,581 | +0.2% | 0.00% | – |
| Q2 2022 | $1,828,000 | -26.1% | 266,038 | +3.7% | 0.00% | – |
| Q1 2022 | $2,474,000 | -20.3% | 256,664 | -1.7% | 0.00% | -100.0% |
| Q4 2021 | $3,106,000 | -25.6% | 261,235 | +1.6% | 0.00% | 0.0% |
| Q3 2021 | $4,177,000 | -26.5% | 257,212 | -4.8% | 0.00% | 0.0% |
| Q2 2021 | $5,686,000 | +108.7% | 270,231 | +54.0% | 0.00% | 0.0% |
| Q1 2021 | $2,724,000 | -20.1% | 175,445 | +8.1% | 0.00% | 0.0% |
| Q4 2020 | $3,408,000 | – | 162,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |